Clinuvel Pharmaceuticals buy dokem
Start price
30.09.16
/
50%
€4.35
Target price
30.03.17
€9.50
Performance (%)
15.31%
End price
30.03.17
€5.02
Summary
This prediction ended on 30.03.17 with a price of €5.02. The BUY prediction by dokem finished with a performance of 15.31%. dokem has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Clinuvel Pharmaceuticals | -6.155% | -6.155% | -25.166% | -50.441% |
| iShares Core DAX® | -0.258% | 0.299% | 15.648% | 15.944% |
| iShares Nasdaq 100 | 2.964% | 4.660% | 32.001% | 57.194% |
| iShares Nikkei 225® | 1.217% | -2.160% | 6.668% | 4.285% |
| iShares S&P 500 | 1.732% | 2.807% | 25.596% | 48.530% |
Comments by dokem for this prediction
In the thread Clinuvel Pharmaceuticals diskutieren
dokem stimmt der Buy-Einschätzung von ValueFox zu
dokem stimmt am 30.09.2016 der Buy-Einschätzung von ValueFox mit dem Kursziel 12,6€ zu.Überschrift: Clinuvel: "strong buy" nach erfolgreichem Markteintritt
(Laufzeit überschritten)